140. ドラベ症候群 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 139 / 薬物数 : 49 - (DrugBank : 17) / 標的遺伝子数 : 53 - 標的パスウェイ数 : 67
薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
12-lead ECG
Gillette Children's Specialty Healthcare
2017 Phase 1/Phase 2 NCT02815540 United States
Ataluren
NYU Langone Health
2016 Phase 2 NCT02758626 United States
BMB-101
Bright Minds Biosciences Pty Ltd
2024 Phase 2 NCT06401538 Australia
Cannabidiol
GW Research Ltd
2015 Phase 3 EUCTR2014-002939-34-NL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002939-34-ES Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 - EUCTR2014-000995-24-PL France;Poland;United Kingdom;United States
2014 Phase 3 EUCTR2014-002939-34-GB Israel;Netherlands;Poland;Spain;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2014-000995-24-GB France;Poland;United Kingdom;United States
- Phase 3 EUCTR2014-002939-34-PL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
Gillette Children's Specialty Healthcare
2017 Phase 1/Phase 2 NCT02815540 United States
Jazz Pharmaceuticals
2021 Phase 4 NCT05044819 United States
Yonsei University
2020 Phase 3 NCT04611438 Korea, Republic of
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2018 Phase 1 NCT03467113 United States
Cannabidiol oral solution
INSYS Therapeutics Inc
2017 Phase 3 NCT02318563 -
Carbidopa
Natsume Jun
2020 Phase 4 JPRN-jRCTs041190116 -
CBD
GW Research Ltd
2015 Phase 3 EUCTR2014-002939-34-NL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002939-34-ES Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 - EUCTR2014-000995-24-PL France;Poland;United Kingdom;United States
2014 Phase 3 EUCTR2014-002939-34-GB Israel;Netherlands;Poland;Spain;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2014-000995-24-GB France;Poland;United Kingdom;United States
- Phase 3 EUCTR2014-002939-34-PL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
CBD: GT4 transdermal delivery system
Alexander Rotenberg
2025 Phase 1/Phase 2 NCT06738732 United States
Clemizole HCL
Epygenix
2020 Phase 3 NCT04462770 Canada;Georgia;Hungary;Poland;Romania;Spain;United Kingdom;United States
Clemizole hydrochloride
Epygenix
2019 Phase 1 NCT04069689 United States
Epygenix Therapeutics, Inc.
2023 Phase 2 EUCTR2021-003425-30-HU Bulgaria;Canada;Georgia;Hungary;India;Poland;Romania;Spain;United Kingdom;United States
2022 Phase 2 EUCTR2021-003425-30-ES Canada;Hungary;Poland;Spain;United Kingdom;United States
- Phase 2 EUCTR2021-003425-30-PL Bulgaria;Canada;Georgia;Hungary;India;Poland;Romania;Spain;United Kingdom;United States
Clobazam
H. Lundbeck A/S
2015 Phase 3 NCT02187809 Mexico;United States
2015 Phase 3 NCT02174094 Mexico;United States
ISTITUTO C. MONDINO
2007 - EUCTR2007-003702-95-IT Italy
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
West China Second University Hospital, Sichuan University
2024 Phase 4 ChiCTR2400088523 China
Diacomit
BIOCODEX
2007 Phase 2 EUCTR2007-001784-30-FR France
Meiji Seika Pharma Co., Ltd.
2012 - JPRN-jRCT1080225085 Japan
Epidiolex 100 MG/ML oral solution
Elizabeth Donner
2025 Phase 4 NCT06924827 Canada
Jazz Pharmaceuticals
2025 - NCT05485831 Italy
EPX-100
Epygenix
2019 Phase 1 NCT04069689 United States
Epygenix Therapeutics, Inc.
2023 Phase 2 EUCTR2021-003425-30-HU Bulgaria;Canada;Georgia;Hungary;India;Poland;Romania;Spain;United Kingdom;United States
2022 Phase 2 EUCTR2021-003425-30-ES Canada;Hungary;Poland;Spain;United Kingdom;United States
- Phase 2 EUCTR2021-003425-30-PL Bulgaria;Canada;Georgia;Hungary;India;Poland;Romania;Spain;United Kingdom;United States
ETX101
Encoded Therapeutics
2024 Phase 1/Phase 2 NCT06283212 United Kingdom
2024 Phase 1/Phase 2 NCT06112275 Australia
2024 Phase 1/Phase 2 NCT05419492 United States
Exome and/or whole genome sequencing
Boston Children's Hospital
2010 - NCT01858285 United States
Fenfluramina cloridrato
ZOGENIX INTERNATIONAL LTD
2016 Phase 3 EUCTR2015-004167-37-IT Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
Zogenix International Limited
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
Fenfluramine
UCB BIOSCIENCES, Inc.
2024 Phase 3 NCT06118255 Belgium;Germany;Italy;Spain;United Kingdom;United States
University Health Network, Toronto
2022 Phase 3 NCT05560282 Canada
University Hospital Antwerp
2011 Phase 3 EUCTR2011-004114-42-BE Belgium
University of California, Los Angeles
2018 - NCT04437004 United States
University of Colorado, Denver
2024 Phase 4 NCT06598449 United States
Fenfluramine hydrochloride
YAMAMOTO Hideichiro
2019 Phase 3 JPRN-jRCT2041200095 Australia;Belgium;Canda;Denmark;France;Germany;Italy;Japan;Korea;Netherland;Norway;Spain;Sweeded;UK;US
Zogenix International Limited
2020 Phase 3 EUCTR2019-001331-31-SE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 JPRN-jRCT2080224792 Australia;Europe;Japan
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-002804-14-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-002804-14-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-GB Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-ES Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-DE Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Norway;Spain;Sweden;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-000474-38-NL Germany;Netherlands;Spain;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-SE Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-GB Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-ES Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-DK Australia;Belgium;Denmark;France;Germany;Italy;Japan;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-DE Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-BE Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
- Phase 3 EUCTR2019-001331-31-PL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2016-002804-14-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2015-004167-37-NO Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
- Phase 3 EUCTR2015-004167-37-FR Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2017 Phase 3 NCT03299842 United States
2017 Phase 3 NCT02926898 Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 NCT02823145 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2016 Phase 3 NCT02682927 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Spain;United Kingdom;United States
Zogenix International Limited, a wholly owned subsidiary of Zogenix Inc.
2016 Phase 3 EUCTR2016-002804-14-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
Zogenix, Inc.
2019 Phase 3 NCT03936777 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 - NCT03780127 -
Frisium*30CPS 10MG
ISTITUTO C. MONDINO
2007 - EUCTR2007-003702-95-IT Italy
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
Gaba blood level
Cook Children's Health Care System
2022 - NCT05651204 United States
GWP42003-P
GW Research Ltd
2015 Phase 3 NCT02224573 -
2015 Phase 3 EUCTR2014-002939-34-NL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002939-34-ES Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 - EUCTR2014-000995-24-PL France;Poland;United Kingdom;United States
2014 Phase 3 EUCTR2014-002939-34-GB Israel;Netherlands;Poland;Spain;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2014-000995-24-GB France;Poland;United Kingdom;United States
- Phase 3 EUCTR2014-002939-34-PL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
Jazz Pharmaceuticals
2021 Phase 3 NCT04485104 Italy;Spain;United States
2015 Phase 3 NCT02224703 Australia;Israel;Netherlands;Poland;Spain;United States
GWP42003-P 10 MG/KG/DAY dose
Jazz Pharmaceuticals
2014 Phase 2 NCT02091206 United Kingdom;United States
GWP42003-P 20 MG/KG/DAY dose
Jazz Pharmaceuticals
2015 Phase 3 NCT02091375 France;Poland;United Kingdom;United States
2014 Phase 2 NCT02091206 United Kingdom;United States
GWP42003-P 5 MG/KG/DAY dose
Jazz Pharmaceuticals
2014 Phase 2 NCT02091206 United Kingdom;United States
Levodopa
Natsume Jun
2020 Phase 4 JPRN-jRCTs041190116 -
Lorcaserin
Eisai Inc.
2021 - NCT04457687 Canada;United States
2020 Phase 3 NCT04572243 Canada;United States
LP352
Longboard Pharmaceuticals
2024 Phase 3 NCT06660394 Australia;Belgium;Brazil;Canada;China;France;Germany;Italy;Latvia;Mexico;Netherlands;Portugal;Serbia;Spain;United Kingdom;United States
2024 - NCT06149663 Australia;United States
2022 Phase 1/Phase 2 NCT05364021 Australia;United States
LP352, bexicaserin
Longboard Pharmaceuticals
2022 Phase 2 NCT05626634 Australia;United States
MIC
Nonomura Hidenori
2022 Phase 3 JPRN-jRCT2051210182 Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russia;Serbia;Spain;USA;Ukraine;United Kingdom
2021 Phase 3 JPRN-jRCT2051210074 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russia;Serbia;Spain;Ukraine;United Kingdom;United States
Multiple
University of Oxford
2023 - NCT05140122 -
None AT this time
Takeda Development Center Americas, Inc.
2019 Phase 2 EUCTR2018-002484-25-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002484-25-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
Other antiepileptics
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
Soticlestat
Nonomura Hidenori
2022 Phase 3 JPRN-jRCT2051210182 Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russia;Serbia;Spain;USA;Ukraine;United Kingdom
2021 Phase 3 JPRN-jRCT2051210074 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russia;Serbia;Spain;Ukraine;United Kingdom;United States
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2022 Phase 3 EUCTR2021-002482-17-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Takeda
2024 Phase 3 NCT06422377 Denmark;United Kingdom
2022 Phase 3 NCT05163314 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 NCT04940624 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2018 Phase 2 NCT03635073 Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
Takeda Development Center America, Inc.
- Phase 2 EUCTR2022-001315-44-Outside-EU/EEA United States
Takeda Development Center Americas, Inc
2023 Phase 3 EUCTR2021-002482-17-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-PL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain
2022 Phase 3 EUCTR2021-002482-17-ES Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-BE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
- Phase 3 EUCTR2021-002480-22-Outside-EU/EEA Australia;Brazil;Canada;China;Japan;Latvia;Russian Federation;Serbia;Ukraine;United States
Takeda Development Center Americas, Inc.
2023 Phase 3 EUCTR2021-002480-22-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-PL Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-ES Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-BE Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2018-002485-39-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002485-39-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
- Phase 3 EUCTR2021-002480-22-FR Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Stiripentol
Children's Hospital Medical Center, Cincinnati
2013 - NCT01983722 United States
Cook Children's Health Care System
2014 - NCT02239276 United States
Mayo Clinic
2012 Phase 4 NCT01533506 United States
Meiji Seika Pharma Co., Ltd.
2012 - JPRN-jRCT1080225085 Japan
Meiji Seika Pharma Co., Ltd. (formerly MEIJI SEIKA KAISHA Co., LTD.)
2010 Phase 3 JPRN-jRCT2080221082 -
University of Colorado, Denver
2013 - NCT01835314 United States
Yushi InoueNational Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders
2007 - JPRN-jRCT1091220014 Japan
Stiripentolo
ISTITUTO C. MONDINO
2007 - EUCTR2007-003702-95-IT Italy
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
STK-001
Stoke Therapeutics, Inc
2021 Phase 2 NCT04740476 United States
STK-001 - multiple ascending doses
Stoke Therapeutics, Inc
2020 Phase 1/Phase 2 NCT04442295 United States
STK-001 - single ascending doses
Stoke Therapeutics, Inc
2020 Phase 1/Phase 2 NCT04442295 United States
TAK-935
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2022 Phase 3 EUCTR2021-002482-17-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Takeda
2018 Phase 2 NCT03650452 Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
Takeda Development Center America, Inc.
- Phase 2 EUCTR2022-001315-44-Outside-EU/EEA United States
Takeda Development Center Americas, Inc
2023 Phase 3 EUCTR2021-002482-17-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-PL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain
2022 Phase 3 EUCTR2021-002482-17-ES Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-BE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
- Phase 3 EUCTR2021-002480-22-Outside-EU/EEA Australia;Brazil;Canada;China;Japan;Latvia;Russian Federation;Serbia;Ukraine;United States
Takeda Development Center Americas, Inc.
2023 Phase 3 EUCTR2021-002480-22-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-PL Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-ES Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-BE Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2018-002485-39-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002485-39-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002484-25-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002484-25-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
- Phase 3 EUCTR2021-002480-22-FR Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Topamax
ISTITUTO C. MONDINO
2007 - EUCTR2007-003702-95-IT Italy
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
Topiramate
ISTITUTO C. MONDINO
2007 - EUCTR2007-003702-95-IT Italy
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
Turmeric
NYU Langone Health
2018 - NCT03254680 United States
Verapamil
Gillette Children's Specialty Healthcare
2012 Phase 2 NCT01607073 United States
Zorevunersen
Stoke Therapeutics, Inc
2025 Phase 3 NCT06872125 -
ZX008
YAMAMOTO Hideichiro
2019 Phase 3 JPRN-jRCT2041200095 Australia;Belgium;Canda;Denmark;France;Germany;Italy;Japan;Korea;Netherland;Norway;Spain;Sweeded;UK;US
ZOGENIX INTERNATIONAL LTD
2016 Phase 3 EUCTR2015-004167-37-IT Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
Zogenix International Limited
2020 Phase 3 EUCTR2019-001331-31-SE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 JPRN-jRCT2080224792 Australia;Europe;Japan
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-002804-14-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-002804-14-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-GB Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-ES Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-DE Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Norway;Spain;Sweden;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-000474-38-NL Germany;Netherlands;Spain;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-SE Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-GB Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-ES Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-DK Australia;Belgium;Denmark;France;Germany;Italy;Japan;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-DE Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-BE Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
- Phase 3 EUCTR2019-001331-31-PL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2016-002804-14-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2015-004167-37-NO Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
- Phase 3 EUCTR2015-004167-37-FR Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2017 Phase 3 NCT03299842 United States
2017 Phase 3 NCT02926898 Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 NCT02823145 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2016 Phase 3 NCT02682927 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Spain;United Kingdom;United States
Zogenix International Limited, a wholly owned subsidiary of Zogenix Inc.
2016 Phase 3 EUCTR2016-002804-14-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
Zogenix, Inc.
2019 Phase 3 NCT03936777 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
ZX008 - 0.2 MG/KG/DAY
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2016 Phase 3 NCT02826863 Australia;Belgium;Denmark;France;Germany;Italy;Japan;Norway;Spain;Sweden;United Kingdom
ZX008 - 0.8 MG/KG/DAY
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2016 Phase 3 NCT02826863 Australia;Belgium;Denmark;France;Germany;Italy;Japan;Norway;Spain;Sweden;United Kingdom
ZX008 0.2 TO 0.8 MG/KG/DAY
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2018 Phase 1 NCT03467113 United States
Gillette Children's Specialty Healthcare
2017 Phase 1/Phase 2 NCT02815540 United States
Ataluren
NYU Langone Health
2016 Phase 2 NCT02758626 United States
BMB-101
Bright Minds Biosciences Pty Ltd
2024 Phase 2 NCT06401538 Australia
Cannabidiol
GW Research Ltd
2015 Phase 3 EUCTR2014-002939-34-NL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002939-34-ES Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 - EUCTR2014-000995-24-PL France;Poland;United Kingdom;United States
2014 Phase 3 EUCTR2014-002939-34-GB Israel;Netherlands;Poland;Spain;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2014-000995-24-GB France;Poland;United Kingdom;United States
- Phase 3 EUCTR2014-002939-34-PL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
Gillette Children's Specialty Healthcare
2017 Phase 1/Phase 2 NCT02815540 United States
Jazz Pharmaceuticals
2021 Phase 4 NCT05044819 United States
Yonsei University
2020 Phase 3 NCT04611438 Korea, Republic of
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2018 Phase 1 NCT03467113 United States
Cannabidiol oral solution
INSYS Therapeutics Inc
2017 Phase 3 NCT02318563 -
Carbidopa
Natsume Jun
2020 Phase 4 JPRN-jRCTs041190116 -
CBD
GW Research Ltd
2015 Phase 3 EUCTR2014-002939-34-NL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002939-34-ES Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 - EUCTR2014-000995-24-PL France;Poland;United Kingdom;United States
2014 Phase 3 EUCTR2014-002939-34-GB Israel;Netherlands;Poland;Spain;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2014-000995-24-GB France;Poland;United Kingdom;United States
- Phase 3 EUCTR2014-002939-34-PL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
CBD: GT4 transdermal delivery system
Alexander Rotenberg
2025 Phase 1/Phase 2 NCT06738732 United States
Clemizole HCL
Epygenix
2020 Phase 3 NCT04462770 Canada;Georgia;Hungary;Poland;Romania;Spain;United Kingdom;United States
Clemizole hydrochloride
Epygenix
2019 Phase 1 NCT04069689 United States
Epygenix Therapeutics, Inc.
2023 Phase 2 EUCTR2021-003425-30-HU Bulgaria;Canada;Georgia;Hungary;India;Poland;Romania;Spain;United Kingdom;United States
2022 Phase 2 EUCTR2021-003425-30-ES Canada;Hungary;Poland;Spain;United Kingdom;United States
- Phase 2 EUCTR2021-003425-30-PL Bulgaria;Canada;Georgia;Hungary;India;Poland;Romania;Spain;United Kingdom;United States
Clobazam
H. Lundbeck A/S
2015 Phase 3 NCT02187809 Mexico;United States
2015 Phase 3 NCT02174094 Mexico;United States
ISTITUTO C. MONDINO
2007 - EUCTR2007-003702-95-IT Italy
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
West China Second University Hospital, Sichuan University
2024 Phase 4 ChiCTR2400088523 China
Diacomit
BIOCODEX
2007 Phase 2 EUCTR2007-001784-30-FR France
Meiji Seika Pharma Co., Ltd.
2012 - JPRN-jRCT1080225085 Japan
Epidiolex 100 MG/ML oral solution
Elizabeth Donner
2025 Phase 4 NCT06924827 Canada
Jazz Pharmaceuticals
2025 - NCT05485831 Italy
EPX-100
Epygenix
2019 Phase 1 NCT04069689 United States
Epygenix Therapeutics, Inc.
2023 Phase 2 EUCTR2021-003425-30-HU Bulgaria;Canada;Georgia;Hungary;India;Poland;Romania;Spain;United Kingdom;United States
2022 Phase 2 EUCTR2021-003425-30-ES Canada;Hungary;Poland;Spain;United Kingdom;United States
- Phase 2 EUCTR2021-003425-30-PL Bulgaria;Canada;Georgia;Hungary;India;Poland;Romania;Spain;United Kingdom;United States
ETX101
Encoded Therapeutics
2024 Phase 1/Phase 2 NCT06283212 United Kingdom
2024 Phase 1/Phase 2 NCT06112275 Australia
2024 Phase 1/Phase 2 NCT05419492 United States
Exome and/or whole genome sequencing
Boston Children's Hospital
2010 - NCT01858285 United States
Fenfluramina cloridrato
ZOGENIX INTERNATIONAL LTD
2016 Phase 3 EUCTR2015-004167-37-IT Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
Zogenix International Limited
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
Fenfluramine
UCB BIOSCIENCES, Inc.
2024 Phase 3 NCT06118255 Belgium;Germany;Italy;Spain;United Kingdom;United States
University Health Network, Toronto
2022 Phase 3 NCT05560282 Canada
University Hospital Antwerp
2011 Phase 3 EUCTR2011-004114-42-BE Belgium
University of California, Los Angeles
2018 - NCT04437004 United States
University of Colorado, Denver
2024 Phase 4 NCT06598449 United States
Fenfluramine hydrochloride
YAMAMOTO Hideichiro
2019 Phase 3 JPRN-jRCT2041200095 Australia;Belgium;Canda;Denmark;France;Germany;Italy;Japan;Korea;Netherland;Norway;Spain;Sweeded;UK;US
Zogenix International Limited
2020 Phase 3 EUCTR2019-001331-31-SE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 JPRN-jRCT2080224792 Australia;Europe;Japan
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-002804-14-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-002804-14-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-GB Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-ES Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-DE Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Norway;Spain;Sweden;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-000474-38-NL Germany;Netherlands;Spain;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-SE Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-GB Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-ES Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-DK Australia;Belgium;Denmark;France;Germany;Italy;Japan;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-DE Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-BE Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
- Phase 3 EUCTR2019-001331-31-PL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2016-002804-14-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2015-004167-37-NO Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
- Phase 3 EUCTR2015-004167-37-FR Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2017 Phase 3 NCT03299842 United States
2017 Phase 3 NCT02926898 Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 NCT02823145 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2016 Phase 3 NCT02682927 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Spain;United Kingdom;United States
Zogenix International Limited, a wholly owned subsidiary of Zogenix Inc.
2016 Phase 3 EUCTR2016-002804-14-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
Zogenix, Inc.
2019 Phase 3 NCT03936777 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 - NCT03780127 -
Frisium*30CPS 10MG
ISTITUTO C. MONDINO
2007 - EUCTR2007-003702-95-IT Italy
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
Gaba blood level
Cook Children's Health Care System
2022 - NCT05651204 United States
GWP42003-P
GW Research Ltd
2015 Phase 3 NCT02224573 -
2015 Phase 3 EUCTR2014-002939-34-NL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-002939-34-ES Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-PL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-NL Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-GB Australia;France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-FR France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 Phase 3 EUCTR2014-001834-27-ES France;Israel;Netherlands;Poland;Spain;United Kingdom;United States
2015 - EUCTR2014-000995-24-PL France;Poland;United Kingdom;United States
2014 Phase 3 EUCTR2014-002939-34-GB Israel;Netherlands;Poland;Spain;United Kingdom;United States
2014 Phase 2;Phase 3 EUCTR2014-000995-24-GB France;Poland;United Kingdom;United States
- Phase 3 EUCTR2014-002939-34-PL Australia;Israel;Netherlands;Poland;Spain;United Kingdom;United States
Jazz Pharmaceuticals
2021 Phase 3 NCT04485104 Italy;Spain;United States
2015 Phase 3 NCT02224703 Australia;Israel;Netherlands;Poland;Spain;United States
GWP42003-P 10 MG/KG/DAY dose
Jazz Pharmaceuticals
2014 Phase 2 NCT02091206 United Kingdom;United States
GWP42003-P 20 MG/KG/DAY dose
Jazz Pharmaceuticals
2015 Phase 3 NCT02091375 France;Poland;United Kingdom;United States
2014 Phase 2 NCT02091206 United Kingdom;United States
GWP42003-P 5 MG/KG/DAY dose
Jazz Pharmaceuticals
2014 Phase 2 NCT02091206 United Kingdom;United States
Levodopa
Natsume Jun
2020 Phase 4 JPRN-jRCTs041190116 -
Lorcaserin
Eisai Inc.
2021 - NCT04457687 Canada;United States
2020 Phase 3 NCT04572243 Canada;United States
LP352
Longboard Pharmaceuticals
2024 Phase 3 NCT06660394 Australia;Belgium;Brazil;Canada;China;France;Germany;Italy;Latvia;Mexico;Netherlands;Portugal;Serbia;Spain;United Kingdom;United States
2024 - NCT06149663 Australia;United States
2022 Phase 1/Phase 2 NCT05364021 Australia;United States
LP352, bexicaserin
Longboard Pharmaceuticals
2022 Phase 2 NCT05626634 Australia;United States
MIC
Nonomura Hidenori
2022 Phase 3 JPRN-jRCT2051210182 Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russia;Serbia;Spain;USA;Ukraine;United Kingdom
2021 Phase 3 JPRN-jRCT2051210074 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russia;Serbia;Spain;Ukraine;United Kingdom;United States
Multiple
University of Oxford
2023 - NCT05140122 -
None AT this time
Takeda Development Center Americas, Inc.
2019 Phase 2 EUCTR2018-002484-25-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002484-25-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
Other antiepileptics
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
Soticlestat
Nonomura Hidenori
2022 Phase 3 JPRN-jRCT2051210182 Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russia;Serbia;Spain;USA;Ukraine;United Kingdom
2021 Phase 3 JPRN-jRCT2051210074 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russia;Serbia;Spain;Ukraine;United Kingdom;United States
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2022 Phase 3 EUCTR2021-002482-17-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Takeda
2024 Phase 3 NCT06422377 Denmark;United Kingdom
2022 Phase 3 NCT05163314 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 NCT04940624 Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2018 Phase 2 NCT03635073 Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
Takeda Development Center America, Inc.
- Phase 2 EUCTR2022-001315-44-Outside-EU/EEA United States
Takeda Development Center Americas, Inc
2023 Phase 3 EUCTR2021-002482-17-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-PL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain
2022 Phase 3 EUCTR2021-002482-17-ES Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-BE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
- Phase 3 EUCTR2021-002480-22-Outside-EU/EEA Australia;Brazil;Canada;China;Japan;Latvia;Russian Federation;Serbia;Ukraine;United States
Takeda Development Center Americas, Inc.
2023 Phase 3 EUCTR2021-002480-22-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-PL Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-ES Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-BE Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2018-002485-39-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002485-39-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
- Phase 3 EUCTR2021-002480-22-FR Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Stiripentol
Children's Hospital Medical Center, Cincinnati
2013 - NCT01983722 United States
Cook Children's Health Care System
2014 - NCT02239276 United States
Mayo Clinic
2012 Phase 4 NCT01533506 United States
Meiji Seika Pharma Co., Ltd.
2012 - JPRN-jRCT1080225085 Japan
Meiji Seika Pharma Co., Ltd. (formerly MEIJI SEIKA KAISHA Co., LTD.)
2010 Phase 3 JPRN-jRCT2080221082 -
University of Colorado, Denver
2013 - NCT01835314 United States
Yushi InoueNational Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders
2007 - JPRN-jRCT1091220014 Japan
Stiripentolo
ISTITUTO C. MONDINO
2007 - EUCTR2007-003702-95-IT Italy
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
STK-001
Stoke Therapeutics, Inc
2021 Phase 2 NCT04740476 United States
STK-001 - multiple ascending doses
Stoke Therapeutics, Inc
2020 Phase 1/Phase 2 NCT04442295 United States
STK-001 - single ascending doses
Stoke Therapeutics, Inc
2020 Phase 1/Phase 2 NCT04442295 United States
TAK-935
TAKEDA DEVELOPMENT CENTER AMERICAS INC.
2022 Phase 3 EUCTR2021-002482-17-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-IT Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Takeda
2018 Phase 2 NCT03650452 Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
Takeda Development Center America, Inc.
- Phase 2 EUCTR2022-001315-44-Outside-EU/EEA United States
Takeda Development Center Americas, Inc
2023 Phase 3 EUCTR2021-002482-17-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-PL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain
2022 Phase 3 EUCTR2021-002482-17-ES Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2022 Phase 3 EUCTR2021-002482-17-BE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
- Phase 3 EUCTR2021-002480-22-Outside-EU/EEA Australia;Brazil;Canada;China;Japan;Latvia;Russian Federation;Serbia;Ukraine;United States
Takeda Development Center Americas, Inc.
2023 Phase 3 EUCTR2021-002480-22-DE Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-PL Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-NL Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-LV Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-HU Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-GR Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Mexico;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United States
2021 Phase 3 EUCTR2021-002480-22-ES Australia;Belgium;Canada;China;France;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2021 Phase 3 EUCTR2021-002480-22-BE Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
2019 Phase 2 EUCTR2018-002485-39-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002485-39-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002484-25-PT Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
2019 Phase 2 EUCTR2018-002484-25-PL Australia;Canada;China;Israel;Poland;Portugal;Spain;United States
- Phase 3 EUCTR2021-002480-22-FR Australia;Belgium;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia;Netherlands;Poland;Russian Federation;Serbia;Spain;Ukraine;United Kingdom;United States
Topamax
ISTITUTO C. MONDINO
2007 - EUCTR2007-003702-95-IT Italy
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
Topiramate
ISTITUTO C. MONDINO
2007 - EUCTR2007-003702-95-IT Italy
Inserm-ISP Pole Recherches cliniques et thérapeutiques
2007 - EUCTR2007-002198-30-IT Italy
Turmeric
NYU Langone Health
2018 - NCT03254680 United States
Verapamil
Gillette Children's Specialty Healthcare
2012 Phase 2 NCT01607073 United States
Zorevunersen
Stoke Therapeutics, Inc
2025 Phase 3 NCT06872125 -
ZX008
YAMAMOTO Hideichiro
2019 Phase 3 JPRN-jRCT2041200095 Australia;Belgium;Canda;Denmark;France;Germany;Italy;Japan;Korea;Netherland;Norway;Spain;Sweeded;UK;US
ZOGENIX INTERNATIONAL LTD
2016 Phase 3 EUCTR2015-004167-37-IT Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
Zogenix International Limited
2020 Phase 3 EUCTR2019-001331-31-SE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2020 Phase 3 EUCTR2019-001331-31-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 JPRN-jRCT2080224792 Australia;Europe;Japan
2019 Phase 3 EUCTR2019-001331-31-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2019 Phase 3 EUCTR2019-001331-31-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-002804-14-NL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-002804-14-IT Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-GB Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-ES Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2017 Phase 3 EUCTR2016-000474-38-DE Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-GB Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-ES Australia;Belgium;Canada;Denmark;France;Germany;Italy;Norway;Spain;Sweden;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-DK Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-002804-14-BE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 EUCTR2016-000474-38-NL Germany;Netherlands;Spain;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-SE Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-GB Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-ES Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-DK Australia;Belgium;Denmark;France;Germany;Italy;Japan;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-DE Australia;Belgium;Denmark;France;Germany;Italy;Norway;Spain;Sweden;Switzerland;United Kingdom
2016 Phase 3 EUCTR2015-004167-37-BE Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
- Phase 3 EUCTR2019-001331-31-PL Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2016-002804-14-FR Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
- Phase 3 EUCTR2015-004167-37-NO Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
- Phase 3 EUCTR2015-004167-37-FR Australia;Belgium;Denmark;France;Germany;Italy;Korea, Republic of;Norway;Spain;Sweden;Switzerland;United Kingdom
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2017 Phase 3 NCT03299842 United States
2017 Phase 3 NCT02926898 Canada;France;Germany;Netherlands;Spain;United Kingdom;United States
2016 Phase 3 NCT02823145 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
2016 Phase 3 NCT02682927 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Japan;Spain;United Kingdom;United States
Zogenix International Limited, a wholly owned subsidiary of Zogenix Inc.
2016 Phase 3 EUCTR2016-002804-14-DE Australia;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Spain;Sweden;United Kingdom;United States
Zogenix, Inc.
2019 Phase 3 NCT03936777 Australia;Belgium;Canada;Denmark;France;Germany;Italy;Mexico;Netherlands;Poland;Spain;Sweden;United Kingdom;United States
ZX008 - 0.2 MG/KG/DAY
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2016 Phase 3 NCT02826863 Australia;Belgium;Denmark;France;Germany;Italy;Japan;Norway;Spain;Sweden;United Kingdom
ZX008 - 0.8 MG/KG/DAY
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2016 Phase 3 NCT02826863 Australia;Belgium;Denmark;France;Germany;Italy;Japan;Norway;Spain;Sweden;United Kingdom
ZX008 0.2 TO 0.8 MG/KG/DAY
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
2018 Phase 1 NCT03467113 United States